{
  "cik": "0000004977",
  "filing_path": "sec_filings\\10K\\0000004977_0000004977-25-000047_afl-20241231.txt",
  "extracted_at": "2025-09-21T20:15:26.005852Z",
  "cover_page": {
    "sections": [
      {
        "heading": "Cover Page",
        "content": "UNITED STATES\nSECURITIES AND EXCHANGE COMMISSION\nWashington, D.C. 20549\nFORM \n10-K\n\n(Mark One)\n☒\nANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n  For the fiscal year ended \nDecember 31\n, 2024\nor\n☐\nTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n  For the transition period from \n\n to \n\nCommission File Number: \n001-07434\n\nAflac Incorporated\n(Exact name of registrant as specified in its charter)\nGeorgia\n58-1167100\n(State or other jurisdiction of incorporation or organization)\n(I.R.S. Employer Identification No.)\n1932 Wynnton Road\nColumbus,\nGeorgia\n31999\n(Address of principal executive offices)\n(ZIP Code)\nRegistrant’s telephone number, including area code: \n706\n.\n323.3431\n\nSecurities registered pursuant to Section 12(b) of the Act:\nTitle of each class\nTrading Symbol(s)\nName of each exchange on which registered\nCommon Stock, $.10 Par Value\nAFL\nNew York Stock Exchange\nSecurities registered pursuant to Section 12(g) of the Act:    None\nIndicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    \nþ\n\nYes\n\n¨\n  No\nIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    \n¨\n  Yes    \nþ\n\nNo\n\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    \nþ\n\nYes\n\n¨\n  No\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    \nþ\n\nYes\n\n¨\n  No\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and \"emerging growth company\" in Rule 12b-2 of the Exchange Act.\nLarge accelerated filer\n\n☑\nAccelerated filer  \n☐\nNon-accelerated filer \n☐\nSmaller reporting company  \n☐\nEmerging growth company\n☐\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. \n☐\n\nIndicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. \n☑\nIf securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. \n☐\nIndicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive oﬃcers during the relevant recovery period pursuant to §240.10D-1(b). \n☐\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).     \n☐\n Yes    \n☑\n  No\nThe aggregate market value of the voting common stock held by non-affiliates of the registrant as of June 28, 2024, was $\n49,825,613,971\n. \nThe number of shares of the registrant’s common stock outstanding at February 18, 2025, with $.10 par value, was \n546,588,291\n. \nDocuments Incorporated By Reference\nCertain information contained in the Notice and Proxy Statement for the Company’s 2025 Annual Meeting of Shareholders is incorporated by reference into Part III hereof.\nAflac Incorporated\nAnnual Report on Form 10-K\nFor the Year Ended December 31, 2024"
      },
      {
        "heading": "Securities registered pursuant to Section 12(b)",
        "content": "Securities registered pursuant to Section 12(b) of the Act:\nTitle of each class\nTrading Symbol(s)\nName of each exchange on which registered\nCommon Stock, $.10 Par Value\nAFL\nNew York Stock Exchange"
      }
    ]
  },
  "stockholders_equity_notes": {
    "sections": [
      {
        "heading": "Shareholders’ equity was $26.1 billion, or $47.45 per share, at December 31, 2024, compared with $22.0 billion, or $38.00 per share, at December 31, 2023. Shareholders’ equity at December 31, 2024 included a cumulative increase of $2.0 billion from the effect of changes in discount rate assumptions on insurance contracts, compared with a corresponding cumulative decrease of $2.6 billion at December 31, 2023, and a net unrealized gain on investment securities and derivatives of $4 million, compared with a net unrealized gain of $1.1 billion at December 31, 2023. Shareholders’ equity at December 31, 2024 also included an unrealized foreign currency translation loss of $5.0 billion, compared with an unrealized foreign currency translation loss of $4.1 billion at December 31, 2023. The annualized return on average shareholders’ equity in 2024 was 22.6%.",
        "content": "Shareholders’ equity was $26.1 billion, or $47.45 per share, at December 31, 2024, compared with $22.0 billion, or $38.00 per share, at December 31, 2023. Shareholders’ equity at December 31, 2024 included a cumulative increase of $2.0 billion from the effect of changes in discount rate assumptions on insurance contracts, compared with a corresponding cumulative decrease of $2.6 billion at December 31, 2023, and a net unrealized gain on investment securities and derivatives of $4 million, compared with a net unrealized gain of $1.1 billion at December 31, 2023. Shareholders’ equity at December 31, 2024 also included an unrealized foreign currency translation loss of $5.0 billion, compared with an unrealized foreign currency translation loss of $4.1 billion at December 31, 2023. The annualized return on average shareholders’ equity in 2024 was 22.6%.\nShareholders’ equity excluding accumulated other comprehensive income (AOCI)\n(2)\n (adjusted book value) was $29.1 billion, or $52.87 per share, at December 31, 2024, compared with $27.5 billion, or $47.55 per share, at December 31, 2023. Adjusted book value excluding foreign currency remeasurement\n(2)\n was $23.4 billion, or $42.46 per share, at December 31, 2024, compared with $23.8 billion, or $41.15 per share, at December 31, 2023. The annualized adjusted return on equity excluding foreign currency remeasurement\n(2)\n in 2024 was 17.3%.\n(1) \nYen/U.S. dollar exchange rates are based on the published MUFG Bank, Ltd. telegraphic transfer middle rate (TTM).\n(2) \nSee the Results of Operations section of this MD&A for a definition of this non-U.S. GAAP financial measure.\nINDUSTRY TRENDS \nThe Company is impacted by financial markets, economic conditions, regulatory oversight and a variety of trends that affect the industries where it competes.\nFinancial and Economic Environment\nThe Company’s business and results of operations are materially affected by conditions in the global capital markets and the economy generally. Stressed conditions, volatility and disruptions in global capital markets, particular markets, or financial asset classes can have an adverse effect on the Company, in part because the Company has a large investment portfolio and its insurance liabilities and derivatives are sensitive to changing market factors. See Item 1A. Risk Factors for the risk factor entitled, \"Difficult conditions in global capital markets and the economy could have a material adverse effect on the Company's investments, capital position, revenue, profitability, and liquidity and harm the Company's business.\"\n33"
      },
      {
        "heading": "Shareholders’ equity excluding accumulated other comprehensive income (AOCI)",
        "content": "Shareholders’ equity excluding accumulated other comprehensive income (AOCI)\n(2)\n (adjusted book value) was $29.1 billion, or $52.87 per share, at December 31, 2024, compared with $27.5 billion, or $47.55 per share, at December 31, 2023. Adjusted book value excluding foreign currency remeasurement\n(2)\n was $23.4 billion, or $42.46 per share, at December 31, 2024, compared with $23.8 billion, or $41.15 per share, at December 31, 2023. The annualized adjusted return on equity excluding foreign currency remeasurement\n(2)\n in 2024 was 17.3%.\n(1) \nYen/U.S. dollar exchange rates are based on the published MUFG Bank, Ltd. telegraphic transfer middle rate (TTM).\n(2) \nSee the Results of Operations section of this MD&A for a definition of this non-U.S. GAAP financial measure.\nINDUSTRY TRENDS \nThe Company is impacted by financial markets, economic conditions, regulatory oversight and a variety of trends that affect the industries where it competes.\nFinancial and Economic Environment\nThe Company’s business and results of operations are materially affected by conditions in the global capital markets and the economy generally. Stressed conditions, volatility and disruptions in global capital markets, particular markets, or financial asset classes can have an adverse effect on the Company, in part because the Company has a large investment portfolio and its insurance liabilities and derivatives are sensitive to changing market factors. See Item 1A. Risk Factors for the risk factor entitled, \"Difficult conditions in global capital markets and the economy could have a material adverse effect on the Company's investments, capital position, revenue, profitability, and liquidity and harm the Company's business.\"\n33"
      },
      {
        "heading": "Shareholders’ equity:",
        "content": "Shareholders’ equity:\nCommon stock of $\n.10\n par value. In thousands: authorized \n1,900,000\n\n  shares in 2024 and 2023; issued \n1,356,763\n shares in 2024 and \n1,355,398\n shares in 2023\n136\n\n136\n\nAdditional paid-in capital\n2,894\n\n2,771\n\nRetained earnings\n52,277\n\n47,993\n\nAccumulated other comprehensive income (loss):\nUnrealized foreign currency translation gains (losses)\n(\n4,998\n)\n(\n4,069\n)\nUnrealized gains (losses) on fixed maturity securities\n24\n\n1,139\n\nUnrealized gains (losses) on derivatives\n(\n20\n)\n(\n22\n)\nEffect of changes in discount rate assumptions\n2,006\n\n(\n2,560\n)\nPension liability adjustment\n10\n\n(\n8\n)\nTreasury stock, at average cost\n(\n26,231\n)\n(\n23,395\n)\nTotal shareholders’ equity\n26,098\n\n21,985\n\nTotal liabilities and shareholders’ equity\n$\n117,566\n\n$\n126,724\n\nSee the accompanying Notes to the Consolidated Financial Statements.\n\n86"
      },
      {
        "heading": "Shareholders' Equity",
        "content": "Shareholders' \nEquity\nBalance at December 31, 2021\n$\n135\n\n$\n2,529\n\n$\n40,963\n\n$\n(\n8,411\n)\n$\n(\n18,185\n)\n$\n17,031\n\nNet earnings\n0\n\n0\n\n4,418\n\n0\n\n0\n\n4,418\n\nUnrealized foreign currency translation  \n  gains (losses) during period, net of \n  income taxes\n0\n\n0\n\n0\n\n(\n1,579\n)\n0\n\n(\n1,579\n)\nUnrealized gains (losses) on fixed maturity \n   securities during period, net of income \n   taxes and reclassification adjustments \n0\n\n0\n\n0\n\n(\n10,304\n)\n0\n\n(\n10,304\n)\nUnrealized gains (losses) on derivatives \n   during period, net of income taxes\n0\n\n0\n\n0\n\n3\n\n0\n\n3\n\nEffect of changes in discount rate assumptions \n   during period, net of income taxes\n0\n\n0\n\n0\n\n13,732\n\n0\n\n13,732\n\nPension liability adjustment during period, \n   net of income taxes\n0\n\n0\n\n0\n\n130\n\n0\n\n130\n\nDividends to shareholders \n(1)\n  ($\n1.62\n per share)\n0\n\n0\n\n(\n1,014\n)\n0\n\n0\n\n(\n1,014\n)\nExercise of stock options\n0\n\n12\n\n0\n\n0\n\n0\n\n12\n\nShare-based compensation \n0\n\n62\n\n0\n\n0\n\n0\n\n62\n\nPurchases of treasury stock\n0\n\n0\n\n0\n\n0\n\n(\n2,425\n)\n(\n2,425\n)\nTreasury stock reissued\n0\n\n38\n\n0\n\n0\n\n36\n\n74\n\nBalance at December 31, 2022\n135\n\n2,641\n\n44,367\n\n(\n6,429\n)\n(\n20,574\n)\n20,140\n\nNet earnings\n0\n\n0\n\n4,659\n\n0\n\n0\n\n4,659\n\nUnrealized foreign currency translation  \n  gains (losses) during period, net of \n  income taxes\n0\n\n0\n\n0\n\n(\n505\n)\n0\n\n(\n505\n)\nUnrealized gains (losses) on fixed maturity \n   securities during period, net of income \n   taxes and reclassification adjustments \n0\n\n0\n\n0\n\n1,841\n\n0\n\n1,841\n\nUnrealized gains (losses) on derivatives \n   during period, net of income taxes\n0\n\n0\n\n0\n\n5\n\n0\n\n5\n\nEffect of changes in discount rate assumptions \n   during period, net of income taxes\n0\n\n0\n\n0\n\n(\n460\n)\n0\n\n(\n460\n)\nPension liability adjustment during period, \n   net of income taxes\n0\n\n0\n\n0\n\n28\n\n0\n\n28\n\nDividends to shareholders \n(1)\n  ($\n1.76\n per share)\n0\n\n0\n\n(\n1,033\n)\n0\n\n0\n\n(\n1,033\n)\nExercise of stock options\n0\n\n13\n\n0\n\n0\n\n0\n\n13\n\nShare-based compensation \n1\n\n74\n\n0\n\n0\n\n0\n\n75\n\nPurchases of treasury stock\n0\n\n0\n\n0\n\n0\n\n(\n2,854\n)\n(\n2,854\n)\nTreasury stock reissued\n0\n\n43\n\n0\n\n0\n\n33\n\n76\n\nBalance at December 31, 2023\n$\n136\n\n$\n2,771\n\n$\n47,993\n\n$\n(\n5,520\n)\n$\n(\n23,395\n)\n$\n21,985\n\n(1) \nDividends to shareholders are recorded in the period in which they are declared.\nSee the accompanying Notes to the Consolidated Financial Statements.\n(continued)\n87"
      },
      {
        "heading": "Shareholders' Equity",
        "content": "Shareholders' \nEquity\nBalance at December 31, 2023\n$\n136\n\n$\n2,771\n\n$\n47,993\n\n$\n(\n5,520\n)\n$\n(\n23,395\n)\n$\n21,985\n\nNet earnings\n0\n\n0\n\n5,443\n\n0\n\n0\n\n5,443\n\nUnrealized foreign currency translation  \n  gains (losses) during period, net of \n  income taxes\n0\n\n0\n\n0\n\n(\n929\n)\n0\n\n(\n929\n)\nUnrealized gains (losses) on fixed maturity \n   securities during period, net of income \n   taxes and reclassification adjustments \n0\n\n0\n\n0\n\n(\n1,115\n)\n0\n\n(\n1,115\n)\nUnrealized gains (losses) on derivatives \n   during period, net of income taxes\n0\n\n0\n\n0\n\n2\n\n0\n\n2\n\nEffect of changes in discount rate assumptions \n   during period, net of income taxes\n0\n\n0\n\n0\n\n4,566\n\n0\n\n4,566\n\nPension liability adjustment during period, \n   net of income taxes\n0\n\n0\n\n0\n\n18\n\n0\n\n18\n\nDividends to shareholders \n(1)\n  ($\n2.08\n per share)\n0\n\n0\n\n(\n1,159\n)\n0\n\n0\n\n(\n1,159\n)\nExercise of stock options\n0\n\n9\n\n0\n\n0\n\n0\n\n9\n\nShare-based compensation \n0\n\n65\n\n0\n\n0\n\n0\n\n65\n\nPurchases of treasury stock\n0\n\n0\n\n0\n\n0\n\n(\n2,868\n)\n(\n2,868\n)\nTreasury stock reissued\n0\n\n49\n\n0\n\n0\n\n32\n\n81\n\nBalance at December 31, 2024\n$\n136\n\n$\n2,894\n\n$\n52,277\n\n$\n(\n2,978\n)\n$\n(\n26,231\n)\n$\n26,098\n\n(1) \nDividends to shareholders are recorded in the period in which they are declared.\nSee the accompanying Notes to the Consolidated Financial Statements.\n88"
      },
      {
        "heading": "Shareholders’ equity, unrealized gains (losses) on fixed maturity securities",
        "content": "Shareholders’ equity, unrealized gains (losses) on fixed maturity securities\n$\n24\n\n$\n1,139\n\nGross Unrealized Loss Aging\nThe following tables show the fair values and gross unrealized losses of the Company's available-for-sale investments, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position at December 31.\n\n2024\n\nTotal\nLess than 12 months\n12 months or longer\n(In millions)\nFair\nValue\nUnrealized\nLosses\nFair\nValue\nUnrealized\nLosses\nFair\nValue\nUnrealized\nLosses\nFixed maturity securities available-\n   for-sale:\nU.S. government and \n    agencies:\nU.S. dollar-denominated\n$\n106\n\n$\n3\n\n$\n59\n\n$\n1\n\n$\n47\n\n$\n2\n\nJapan government and \n    agencies:\nYen-denominated\n8,136\n\n2,234\n\n2,070\n\n57\n\n6,066\n\n2,177\n\nMunicipalities:\nU.S. dollar-denominated\n666\n\n53\n\n67\n\n3\n\n599\n\n50\n\nYen-denominated\n341\n\n79\n\n96\n\n2\n\n245\n\n77\n\nMortgage- and asset- \n    backed securities:\nU.S. dollar-denominated\n567\n\n34\n\n173\n\n2\n\n394\n\n32\n\nYen-denominated\n196\n\n23\n\n12\n\n0\n\n184\n\n23\n\nPublic utilities:\nU.S. dollar-denominated\n1,570\n\n151\n\n699\n\n19\n\n871\n\n132\n\nYen-denominated\n1,020\n\n108\n\n368\n\n11\n\n652\n\n97\n\nSovereign and supranational:\nYen-denominated\n47\n\n8\n\n0\n\n0\n\n47\n\n8\n\nBanks/financial institutions:\nU.S. dollar-denominated\n625\n\n36\n\n376\n\n7\n\n249\n\n29\n\nYen-denominated\n3,197\n\n342\n\n471\n\n22\n\n2,726\n\n320\n\nOther corporate:\nU.S. dollar-denominated\n6,097\n\n752\n\n2,036\n\n59\n\n4,061\n\n693\n\nYen-denominated    \n1,733\n\n305\n\n289\n\n14\n\n1,444\n\n291\n\nTotal\n$\n24,301\n\n$\n4,128\n\n$\n6,716\n\n$\n197\n\n$\n17,585\n\n$\n3,931\n\n110"
      },
      {
        "heading": "SHAREHOLDERS' EQUITY",
        "content": "SHAREHOLDERS' EQUITY\nShare Data:\n\nThe following table is a reconciliation of the number of shares of the Company's common stock for the years ended December 31.\n(In thousands of shares)\n2024\n2023\n2022\nCommon stock - issued:\nBalance, beginning of period\n1,355,398\n1,354,079\n1,352,739\nExercise of stock options and issuance of restricted shares\n1,365\n1,319\n1,340\nBalance, end of period\n1,356,763\n1,355,398\n1,354,079\nTreasury stock:\nBalance, beginning of period\n776,919\n738,823\n700,607\nPurchases of treasury stock:\nShare repurchase program\n30,428\n38,896\n39,187\nOther\n494\n364\n370\nDispositions of treasury stock:\nShares issued to AFL Stock Plan\n(\n751\n)\n(\n897\n)\n(\n1,009\n)\nExercise of stock options\n(\n104\n)\n(\n88\n)\n(\n117\n)\nOther\n(\n187\n)\n(\n179\n)\n(\n215\n)\nBalance, end of period\n806,799\n776,919\n738,823\nShares outstanding, end of period\n549,964\n578,479\n615,256\nShare Repurchase Program:\n  In November 2022, the Company's board of directors authorized the purchase of an additional \n100\n million shares of its common stock. As of December 31, 2024, a remaining balance of \n47.3\n million shares of the Company's common stock was available for purchase under share repurchase authorizations by its board of directors.\nDuring 2024, the Company repurchased \n30.4\n million shares of its common stock in the open market for $\n2.8\n billion. The Company repurchased \n38.9\n million shares for $\n2.8\n billion in 2023 and \n39.2\n million shares for $\n2.4\n billion in 2022.\nVoting Rights:\n\nIn accordance with the Parent Company's articles of incorporation, shares of common stock \nare generally entitled to \none\n vote per share until they have been held by the same beneficial owner for a continuous period of \n48\n months, at which time they become entitled to \n10\n votes per share.\nEPS: \nA reconciliation of basic and diluted weighted-average shares outstanding used in the computation of basic and diluted EPS for the years ended December 31 is as follows: \n(In thousands of shares)\n2024\n2023\n2022\nWeighted-average outstanding shares used for calculating basic EPS\n562,492\n\n596,173\n\n634,816\n\nDilutive effect of share-based awards\n2,523\n\n2,572\n\n2,839\n\nWeighted-average outstanding shares used for calculating diluted EPS\n565,015\n\n598,745\n\n637,655\n\nOutstanding share-based awards are excluded from the calculation of weighted-average shares used in the computation of basic EPS, but are included in the calculation of weighted-average shares used in the computation of diluted EPS. Anti-dilutive share-based awards are excluded from the computation of diluted EPS. \nThe following table presents the approximate number of share-based awards to purchase shares, on a weighted-average basis, that were considered to be anti-dilutive and were excluded from the calculation of diluted EPS at December 31: \n(In thousands)\n2024\n2023\n2022\nAnti-dilutive share-based awards\n17\n\n51\n\n118\n\n167"
      },
      {
        "heading": "Shareholders' equity:",
        "content": "Shareholders' equity:\nCommon stock of $\n.10\n par value. In thousands: authorized \n1,900,000\n\n  shares in 2024 and 2023; issued \n1,356,763\n shares in 2024 and \n1,355,398\n\n  shares in 2023\n136\n\n136\n\nAdditional paid-in capital\n2,894\n\n2,771\n\nRetained earnings\n52,277\n\n47,993\n\nAccumulated other comprehensive income (loss):\nUnrealized foreign currency translation gains (losses)\n(\n4,998\n)\n(\n4,069\n)\nUnrealized gains (losses) on fixed maturity securities\n24\n\n1,139\n\nUnrealized gains (losses) on derivatives\n(\n20\n)\n(\n22\n)\nEffect of changes in discount rate assumptions\n2,006\n\n(\n2,560\n)\nPension liability adjustment\n10\n\n(\n8\n)\nTreasury stock, at average cost\n(\n26,231\n)\n(\n23,395\n)\nTotal shareholders' equity\n26,098\n\n21,985\n\nTotal liabilities and shareholders' equity\n$\n34,584\n\n$\n29,946\n\n(1)\nEliminated in consolidation\nSee the accompanying Notes to Condensed Financial Statements.\nSee the accompanying"
      }
    ]
  },
  "exhibit_4_securities": {
    "sections": []
  },
  "charter_bylaws": {
    "sections": []
  },
  "market_equity": {
    "sections": []
  }
}